Vancouver, BC, CANADA -- May 31, 2019 -- InvestorsHub
NewsWire -- INVICTUS MD STRATEGIES CORP. ("Invictus" or the
"Company") (TSXV: GENE; OTCQX: IVITF; FRA:
8IS2) announces that the Board of Directors (the
“
Board”) has accepted Mr. George E. Kveton’s
resignation as Chief Executive Officer (“
CEO”) of
the Company and Mr. Trevor Dixon, a member of the Board, will be
assuming the role of CEO.
“I am proud to be serving as the Company’s CEO,” said Mr. Dixon.
“I am committed to the long term and ongoing success of the
Company as we work to improve production, increase revenue and
decrease the cost of operations. With my thirty-five years
experience of founding, developing and operating successful
companies, I am confident I can further Invictus’ presence in the
cannabis industry,” Mr. Dixon continued, “as a significant
shareholder of the Corporation, I am dedicated to generating value
for the Company’s investors.”
Mr. Dixon was appointed a Director and Chief Operating Officer of
the Company on May 9
th, 2019, and he also served as a
Director of the Company from April 2017 to January 2019. Mr.
Dixon remains founder, President and CEO of the Company’s wholly
owned subsidiary Acreage Pharms Ltd. (“
Acreage
Pharms”). Assuming the role of CEO, Mr. Dixon brings
more than seven years’ of knowledge inventing and creating systems
for the production of quality cannabis. Prior to this, Mr.
Dixon developed marketing systems, strategy and product development
for an international franchise business that he founded and
eventually sold after nineteen successful years of ownership.
He also pursued municipal politics for five years. It was
during his time in politics that he discovered the proposed new
legislation on the then
Access to Cannabis for Medical Purposes
Regulations and immediately recognized the value of a
complete seed to sale business and founded Acreage Pharms in
2013. Today, Acreage Pharms supplies recreational cannabis to
British Columbia, Alberta, Saskatchewan and Ontario and is approved
to supply medical cannabis to clients in all provinces in
Canada.
“Mr. Dixon’s success with Acreage Pharms and his focused leadership
will help Invictus reach the next level with production scaling
being his top priority as he works to increase collaboration across
Invictus’ subsidiaries to maximize their potential,” said Paul
Sparkes, Chairman of the Board of Invictus.
Mr. Kveton has worked to ensure a smooth transition for Mr. Dixon
in his new role and said, “It has been a great privilege to have
stewarded Invictus during an important period of transformation. I
strongly believe that the fabric of the Company is strong, made up
of experienced Board members and many talented employees across all
levels and provinces.”
Mr. Sparkes stated, “On behalf of the Board, we wish to thank
George for his valued leadership and for implementing the
difficult, but necessary changes to put the Company on the right
performance track. We wish him all the best.”
On Behalf of the Board,
Paul Sparkes
Chairman of the Board
connect@invictus-md.com
Investor Relations 1-844-800-6086
Neither the TSX Venture Exchange nor its Regulation Services
Provider accepts responsibility for the adequacy or accuracy of
this release.